Comment on the Article “The Effect of Pharmacological Thromboprophylaxis, Tourniquet and Drainage on Hemorrhagic Complications in the Early Stage after Knee Arthroplasty: Preliminary Results”
- Authors: Belov M.V.1
-
Affiliations:
- Solovyеv Clinical Hospital, Yaroslavl State Medical University
- Issue: Vol 25, No 3 (2019)
- Pages: 81-83
- Section: Clinical studies
- URL: https://ogarev-online.ru/2311-2905/article/view/125095
- DOI: https://doi.org/10.21823/2311-2905-2019-25-3-81-83
- ID: 125095
Cite item
Abstract
.
About the authors
M. V. Belov
Solovyеv Clinical Hospital,Yaroslavl State Medical University
Author for correspondence.
Email: micbelov@yandex.ru
Cand. Sci. (Med.), Head of Department of Arthroplasty; Associate professor, Department of Traumatology and Orthopedics
Yaroslavl
Russian FederationReferences
- Liu J., Zhao J., Yan Y., Su J. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(9):e14539. doi: 10.1097/MD.0000000000014539.
- Memtsoudis S.G., Pumberger M., Ma Y., Chiu Y.L., Fritsch G., Gerner P. et al. Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty. J Orthop Res. 2012;30(11):1811-1821. doi: 10.1002/jor.22139.
- Kinov P., Tanchev P.P., Ellis M., Volpin G. Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations. Int Orthop. 2014;38(1):169-175. doi: 10.1007/s00264-013-2134-8.
- Профилактика венозных тромбоэмболических осложнений в травматологии и ортопедии. Российские клинические рекомендации. Травматология и ортопедия России. 2012;1(приложение):2-24.
- Markovic-Denic L., Zivkovic K., Lesic A., Bumbasirevic V., Dubljanin-Raspopovic E., Bumbasirevic M. Risk factors and distribution of symptomatic venous chromboembolism in total hip and knee replacements: prospective study. Int Orthop. 2012;36(6):1299-1305. doi: 10.1007/s00264-011-1466-5.
- Falck-Ytter Y., Francis C.W., Johanson N.A., Curley C., Dahl O.E., Schulman S. [et al.] Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-e325S. doi: 10.1378/chest.11-2404.
- Anderson D.R., Dunbar M., Murnaghan J., Kahn S.R., Gross P., Forsythe M. et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018;378(8):699-707. doi: 10.1056/NEJ Moa1712746.
- Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355(9212):1295-1302. doi: 10.1016/S0140-6736(00)02110-3.
- Anderson D.R., Dunbar M.J., Bohm E.R., Belzile E., Kahn S.R., Zukor D. et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med. 2013;158(11):800-806. doi: 10.7326/0003-4819-158-11-201306040-00004.
- Arsoy D., Giori N.J., Woolson S.T. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA. Clin Orthop Relat Res. 2018;476(2):381-387. doi: 10.1007/s11999.0000000000000041.
- Yhim H.Y., Lee J., Lee J.Y., Lee J.O., Bang S.M. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study. PLoS One. 2017;12(5):e0178214. doi: 10.1371/journal.pone.0178214.
- Alcelik I., Pollock R.D., Sukeik M., Bettany-Saltikov J., Armstrong P.M., Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty. 2012;27(3):331-340. doi: 10.1016/j.arth.2011.04.046.
Supplementary files
